Vimarsana
Biggest News Aggregation in the World

Page 27 - Caredx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Today - Breaking & Trending Today

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm - Vimarsana News

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm

02.11.2021 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CareDx, Inc (“CareDx” or “the Company”) (NASDAQ: CDNA) for violations of the securities laws. The investigation ...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CareDx, Inc. (CDNA) on Behalf of Investors - Vimarsana News

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CareDx, Inc. (CDNA) on Behalf of Investors

30.10.2021 - Law Offices of Howard G. Smith announces an investigation on behalf of CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) investors concerning the Company’s possible violations of the federal securities laws. On October 28, 2021, after the ...

LOST MONEY IN CAREDX, INC.? Gibbs Law Group Investigates Potential Securities Law Violations - Vimarsana News

LOST MONEY IN CAREDX, INC.? Gibbs Law Group Investigates Potential Securities Law Violations

Shares of CareDx, Inc. plummeted more than 27% on Friday, October 29, 2021, after the company disclosed that the Department of Justice and SEC have launched investigations related to CareDx’s... | October 30, 2021

CareDx v. Natera Patent Litigation - Vimarsana News

CareDx v. Natera Patent Litigation

In CareDx v. Natera Civ. Action No. 19-0567-CFC-CJB Consolidated, Judge Connolly ruled that the diagnostic method claimed in U. S. Pat. No. 8,703,652 and two others was a patent-ineligible natural phenomenon.

AlloSure, the First dd-cfDNA in Heart and Kidney - Vimarsana News

AlloSure, the First dd-cfDNA in Heart and Kidney

AlloSure Significantly Improves Management of High-Risk Lung Transplant Patients...